Last edition
News about "Zydus Lifesciences"
Feldan's proprietary Shuttle peptide technology enables the efficient and targeted delivery of biomolecules into cells, unlocking new therapeutic possibilities.
Zydus Lifesciences | 17/04/2025 | By Abha
Zydus Lifesciences Introduces ANVIMO for Kidney and HSCT Transplant Patients
CMV infection remains one of the most serious complications in transplant patients, often leading to graft failure, decreased survival and prolonged hospital stays.
Zydus Lifesciences | 06/03/2025 | By Aishwarya
Zydus Lifesciences to Launch Protection Against New Strain of Influenza Virus
The Quadrivalent Inactivated Influenza vaccine has been developed at the Vaccine Technology Centre (VTC) in Ahmedabad which has proven capabilities in researching, developing, and manufacturing of safe and efficacious vaccines.
Zydus Lifesciences | 28/02/2025 | By Aishwarya
Zydus and Synthon to Commercialise Novel 505(B)(2) Oncology Product in US
Under the terms of this agreement, Synthon will be responsible for the development, manufacturing and supply of the finished product.
Zydus Lifesciences | 13/02/2025 | By Aishwarya | 122
Zydus Reports Robust Growth in Q3 FY25 with a 17 Percent Increase in Revenue
Zydus Lifesciences recorded revenue from operations at INR 52,691 million, marking a 17 percent increase year-over-year.
Zydus Lifesciences | 06/02/2025 | By Aishwarya | 194
Zydus's Chairman Pankaj R Patel Conferred with Padma Bhushan
With a Masters in Pharmaceutics and Pharmaceutical Technology from the L.M. College of Pharmacy and an alumni of the Indian Institute of Management (IIM), Ahmedabad, he was always driven by a passion to become a pharma entrepreneur.
Zydus Lifesciences | 27/01/2025 | By Aishwarya | 164
Zydus Signs Licensing and Supply Agreement with Viwit Pharmaceuticals
As per the terms of the agreement, Viwit will be responsible for ANDA submission, manufacturing and supplying the generic versions of GADAVISTTM and DOTAREM, following the receipt of requisite regulatory approval.
Zydus Lifesciences | 16/09/2024 | By Aishwarya | 199
Zydus Gets Final Approval from USFDA for Scopolamine Transdermal System
Scopolamine Transdermal System is indicated to prevent nausea and vomiting after anaesthesia, narcotic pain medicines, and surgery.
Zydus Lifesciences | 31/08/2024 | By Aishwarya | 174
Zydus Gets Approval from COFEPRIS to Market Mamitra
Zydus Lifesciences has announced that COFEPRIS (Federal Commission for the Protection Against Sanitary Risk) has granted marketing approval for Mamitra, a Trastuzumab biosimilar.
Zydus Lifesciences | 31/07/2024 | By Aishwarya | 163
Zydus Gets Tentative Approval from USFDA for Azilsartan Medoxomil Tablets
Zydus Lifesciences Ltd. has secured a tentative approval from the United States Food and Drug Administration (USFDA) to market Azilsartan Medoxomil Tablets, 40 mg and 80 mg (USRLD: Edarbi tablets).
Zydus Lifesciences | 06/07/2024 | By Aishwarya | 247
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy